Filing Flows › LanzaTech Global (LNZA) › Q1 2026 › vs Q1 2025
LanzaTech Global (LNZA) Q1 2026 vs Q1 2025 (year over year)
LanzaTech Global's revenue rose $2.5M (+27%) from $9.5M in Q1 2025 to $12.0M in Q1 2026. The biggest changes: Biorefining revenue +$4.1M (+145%); Contract research −$387K (-28%); CarbonSmart product −$154K (-4%).
LanzaTech Global, Q1 2026: revenue $12.0M (+27% year over year), operating margin -81.6%, net loss $14.7M, operating cash flow −$9.3M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Engineering and other services | $6.4M | $1.8M | $4.6M | +254% |
| Licensing | $595K | $1.1M | −$456K | -43% |
| Biorefining revenue | $7.0M | $2.9M | $4.1M | +145% |
| CarbonSmart product | $4.0M | $4.2M | −$154K | -4% |
| Contract research | $989K | $1.4M | −$387K | -28% |
| Revenue | $12.0M | $9.5M | $2.5M | +27% |
| Net loss | $14.7M | $19.2M | −$4.5M | -24% |
| Costs & expenses | $26.7M | $40.5M | −$13.8M | -34% |
| Operating costs | $21.8M | $40.5M | −$18.7M | -46% |
| Interest & other, net | $4.9M | −$11.8M | $16.7M | — |
| Research & development | $4.0M | $16.5M | −$12.5M | -76% |
| SG&A | $8.6M | $15.7M | −$7.2M | -45% |
| Other operating costs | $9.2M | $8.3M | $936K | +11% |
| Operating cash sources | $14.7M | $19.2M | −$4.5M | -24% |
| Depreciation | $939K | $781K | $158K | +20% |
| Share-based compensation | $1.3M | $2.3M | −$953K | -42% |
| Working capital & other | $3.1M | −$4.9M | $8.1M | — |
| Cash used in operations | $9.3M | $21.1M | −$11.8M | -56% |
| Net loss absorbed | $14.7M | $19.2M | −$4.5M | -24% |
Questions
How much did LanzaTech Global's revenue grow year over year in Q1 2026?
LanzaTech Global's revenue rose $2.5M (+27%) from $9.5M in Q1 2025 to $12.0M in Q1 2026.
What drove LanzaTech Global's revenue change in Q1 2026?
Biorefining revenue +$4.1M (+145%); Contract research −$387K (-28%); CarbonSmart product −$154K (-4%).